New Intravenous Antibiotics: A Focused Pharmacotherapy Update
A. Connor, PharmD, BCPS, BCNSP
New Intravenous Antibiotics: A Focused Pharmacotherapy Update: Read Article
Take Test

Learning Objectives

At the completion of this program, you will be able to:
  • Describe the mechanisms and pharmacologic actions of telavancin, doripenem, tigecycline, and daptomycin.
  • Identify the organisms against which telavancin, doripenem, tigecycline, and daptomycin are effective.
  • Discuss the safety considerations and nursing implications associated with each of the new antibiotics.

Continuing Education Information

CE ID: ACC2131
Total Contact Hours: 1.00
Pharma Hours: 1.00
Synergy Cat: A
Test Expires: 9/1/2014


New Intravenous Antibiotics: A Focused Pharmacotherapy Update

Publication/Sponsor Information

All rights reserved. No part of this book may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in critical articles or reviews. Permission to photocopy articles: This publication is protected by copyright. Permission to photocopy must be secured in writing from: Permissions Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106-3621; fax: 215-521-8466 or Copyright Clearance Center CCC, 222 Rosewood Dr., Danvers, MA 01923; phone: 978-750-8400; fax: 978-750-4470;

You have currently started taking the test for . To continue your test in progress, select Return to Test. To abandon this test select Cancel.

Your Feedback